Education
About Us
Working with TipRanks
Follow Us
Pharmacorp Rx Inc. (TSE:PCRX)
:PCRX
PCRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.23 - C$0.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)17.25K
Market Cap
C$49.88M
Enterprise ValueC$52.64M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.38
Next Earnings
May 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding105,018,230
10 Day Avg. Volume14,163
30 Day Avg. Volume17,252
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)45.25
Price to Cash Flow (P/CF)-24.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Pharmacorp Rx Inc. News
PremiumCompany Announcements
PharmaCorp Acquires Pre-1954 Charter Company to Expand in OntarioPremiumCompany Announcements
PharmaCorp Rx Expands Its Canadian Pharmacy NetworkPremiumCompany Announcements
PharmaCorp Expands with Atlantic Canada Pharmacy Acquisition
PremiumCompany Announcements
Pharmacorp Rx Inc. Expands with Atlantic Canada Acquisition
PremiumCompany Announcements
Pharmacorp Rx Inc. Expands with New Pharmacy Acquisition---
PCRX FAQ
What was Pharmacorp Rx Inc.’s price range in the past 12 months?
Pharmacorp Rx Inc. lowest stock price was C$0.23 and its highest was C$0.88 in the past 12 months.
What is Pharmacorp Rx Inc.’s market cap?
Pharmacorp Rx Inc.’s market cap is C$49.88M.
When is Pharmacorp Rx Inc.’s upcoming earnings report date?
Pharmacorp Rx Inc.’s upcoming earnings report date is May 29, 2025 which is in 31 days.
How were Pharmacorp Rx Inc.’s earnings last quarter?
Currently, no data Available
Is Pharmacorp Rx Inc. overvalued?
According to Wall Street analysts Pharmacorp Rx Inc.’s price is currently Overvalued.
Does Pharmacorp Rx Inc. pay dividends?
Pharmacorp Rx Inc. does not currently pay dividends.
What is Pharmacorp Rx Inc.’s EPS estimate?
Pharmacorp Rx Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmacorp Rx Inc. have?
Pharmacorp Rx Inc. has 105,018,230 shares outstanding.
What happened to Pharmacorp Rx Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pharmacorp Rx Inc.?
Currently, no hedge funds are holding shares in TSE:PCRX
---
Company Description
Pharmacorp Rx Inc.
Proton Capital Corp is a Capital Pool Company. The principal business of the Company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.
---
Technical Analysis
Theratechnologies
―
Knight Therapeutics
―
Resverlogix
―
Neo Performance Materials Inc
―
HLS Therapeutics Inc
―
---